SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GUMM - Eliminate the Common Cold

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mike M who wrote (2469)4/1/2000 10:12:00 AM
From: Hank  Read Replies (1) of 5582
 
GUMM prepares it's lemming shareholders for bad news as they prove once more that they are, have always been, and will always be, a NET money LOSER:

"The delay in keeping product fully stocked on the shelves in December, coupled with a very short cold season, which peaked in early January and declined much more rapidly than normal in January, February and March, limited our ability to fully realize during the 1999-2000 cold season what we believe is the significant market potential of Zicam(TM) Cold Remedy. The very short cold season in particular limited the level of reorders during the first quarter." "
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext